1. Home
  2. CTS vs PLSE Comparison

CTS vs PLSE Comparison

Compare CTS & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CTS Corporation

CTS

CTS Corporation

HOLD

Current Price

$44.31

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$14.27

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTS
PLSE
Founded
1896
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
CTS
PLSE
Price
$44.31
$14.27
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$22.00
AVG Volume (30 Days)
191.3K
183.4K
Earning Date
02-03-2026
11-05-2025
Dividend Yield
0.36%
N/A
EPS Growth
3.07
N/A
EPS
1.98
N/A
Revenue
$531,522,000.00
$86,000.00
Revenue This Year
$5.73
N/A
Revenue Next Year
$4.00
$1,002.94
P/E Ratio
$22.47
N/A
Revenue Growth
3.61
N/A
52 Week Low
$34.02
$12.56
52 Week High
$57.49
$25.00

Technical Indicators

Market Signals
Indicator
CTS
PLSE
Relative Strength Index (RSI) 56.37 48.18
Support Level $42.68 $13.12
Resistance Level $45.71 $14.75
Average True Range (ATR) 1.21 0.64
MACD 0.09 0.23
Stochastic Oscillator 65.27 61.94

Price Performance

Historical Comparison
CTS
PLSE

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: